Publication | Open Access
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial
32
Citations
66
References
2024
Year
Lymphoid NeoplasiaMedicineImmunologyPharmacologyPhase 1B/2aPharmacotherapyAdult T-cell Leukemia-lymphomaImmunotherapyOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1